A new study found that continuous glucose monitors can cut healthcare costs by about 20% while also improving outcomes for insulin-dependent diabetes patients, largely by reducing hospitalizations and emergency department visits. Despite these benefits and broad insurance coverage, roughly 80% of eligible patients still are not using the technology — highlighting a significant adoption gap.
CMS’ new ACCESS model, slated to begin on July 1, aims to shift traditional Medicare fee-for-service toward value-based care by tying payments to patient outcomes and encouraging tech-enabled, preventive care. Experts say it could benefit digitally mature, value-focused providers first, but its overall success will hinge on clear metrics, better data sharing and sustained participation.
Greenway Health blends smart technology with human expertise to elevate revenue cycle.
Oura has evolved from a sleep-focused wellness startup into a company getting deeper and deeper into chronic disease management and healthcare integration. Ricky Bloomfield, the company’s chief medical officer, said Oura wants to integrate more of its data into healthcare workflows — in ways that are clinically meaningful, not burdensome, for physicians, he emphasized.
Goodpath’s Series A round was led by MassMutual Ventures and included participation from Healthy Ventures. In total, the company has raised $22 million.
Corewell Health is seeing positive results from its partnership with Nudj Health, a startup that delivers virtual lifestyle medicine programs. More than 3,600 Corewell patients have enrolled in Nudj’s programs since 2023 — and their reported improvements include weight loss, reduced depression and anxiety levels, better cholesterol and triglyceride levels, and increased daily exercise minutes.
Employers have a unique opportunity to shift from reactive to proactive care, in an unprecedented way. By grounding benefits strategies in clinical innovation and time-tested behavior change, healthy aging and enhanced quality of life is more achievable than ever before.
Across the nation, state-based health insurance exchanges are searching for ways to better serve their communities while making enrollment easier, more personal, and more accessible for everyone.
GLP-1 medications are transforming how we think about chronic disease management and, more importantly, prevention. Ongoing research has found them to be effective in the prevention or treatment of diabetes, heart attacks and strokes, kidney disease, liver disease, sleep apnea, and more.
Poverty significantly impacts the mental and physical health of older adults. Lack of access to care and unaddressed SDOH issues lead to poorly managed chronic conditions, delays in treatment, medication non-adherence, and lower utilization of preventive services.
It’s critical that healthcare organizations delivering on the program’s promise not be torpedoed by the “bad actors”
For GLP-1 receptor agonists specifically, adherence challenges are a major concern, as these medications require long-term use to achieve meaningful health benefits in chronic conditions like diabetes and obesity.
How can AI benefit and improve patient outcome in the emergency department? Watch the latest episode to find out.
Medicare Advantage plans can more effectively position themselves for success under an evolving measurement system. Here are three strategic actions health plan leaders should prioritize to enhance 2026 bids to secure stronger Star Rating performance.
The best “gift” for a person with chronic conditions is the emotional support and education needed to stay adherent to medications during the hectic holiday season.
Though chronic disease treatment is rapidly expanding, balancing the latest medication with proven initiatives can help employers manage rising healthcare costs wherever you fall on the GLP-1 coverage spectrum.
As we send our kids back to school this fall, let's remember that a healthy smile is about more than looks — it's about giving our children the best possible start in life, free from the pain and distraction of dental problems, which are likely to occur if left untreated.
Better Health's $14 million in funding included investments from Healthworx, the University of Miami Health System and Mosaic General Partnership.